Virtual Clinical Trials, are not a new concept, but have experienced a boost during COVID-19. The pandemic has pushed pharma companies to increase adoption of virtual trials, as patient feels insecure when visiting sites. 

Going virtual with your clinical trial can boost a lot of postives. It  enable fewer on-site visits for the patient or eliminate them completely. The patient base can widen over a larger area as there is no need to go to a site and with app and email reminders the patient adherence can be increased. 

However going virtual is not a “one-size fits all” solution. In This white paper we will take a closer look at some of the pitfalls when planning a virtual trial.  

Subscribe to our newsletter or read our whitepapers.

Download the whitepaper

    You must agree before submitting.

    For more information on how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

    Input this code: captcha